BUKWANG PHARMACEUTICAL IND CO.,LTD Q3 revenue KRW 56.1 billion, operating profit KRW 1.7 billion
AI summary · Not investment advice
Bukwang Pharmaceutical sold KRW 56.1 billion in Q3 and earned KRW 1.7 billion from its main business, up 76.4% from a year earlier and 22.5% from the prior quarter.
Operating profit · 3 months
KRW 1.7 billion
Key facts
- Revenue (3 months)
- KRW 56.1 billion
- Net income (3 months)
- KRW 338.8 million
- Period
- Q3 (cumulative 2026.01.01 ~ 2026.09.30)
- Revenue (prior-year 3 months)
- KRW 47.8 billion
- Revenue (year to date)
- KRW 160.8 billion
- Operating profit (prior-year 3 months)
- KRW 979.1 million
- Operating profit (year to date)
- KRW 4.2 billion
- Net income (prior-year 3 months)
- KRW 1.5 billion
- Net income (year to date)
- KRW 2.9 billion
Commentary
AI commentary · Not investment advice
What happened
Bukwang Pharmaceutical filed its quarterly report with consolidated results for the third quarter of 2026.
In the company's terms
Sales for the 3 months were KRW 56.07 billion. That is 17.3% above the same 3 months a year earlier, and 1.6% below the previous quarter. Cumulative sales this year are KRW 160.83 billion.
What changes for shareholders
Operating profit (profit from the core business) for the 3 months was KRW 1.73 billion. That is 76.4% above a year earlier and 22.5% above the previous quarter. Cumulative operating profit this year is KRW 4.24 billion.
Net income (the final profit after taxes and other costs) for the 3 months was KRW 0.34 billion. That is 77.4% below a year earlier and 75.6% below the previous quarter. Cumulative net income this year is KRW 2.89 billion.
Comments
No comments yet
Comments from shareholders will appear here.
Ad
Verify your holdings and catch the next disclosure
Verify the stocks you hold and get new disclosures as app alerts.

App design sample
Get the next disclosure as an app alert
Get app alerts for new disclosures and stake changes on your watchlist
B